These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11364417)

  • 1. 3TC receives full approval.
    Grodeck B; Vazquez E
    Posit Aware; 1997; 8(3):11. PubMed ID: 11364417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3TC recommended for hepatitis B.
    Body Posit; 1999 Apr; 12(4):39. PubMed ID: 11366278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA panel backs Glaxo Wellcome drug for use in treating chronic hepatitis B. Food and Drug Administration.
    Newsline People AIDS Coalit N Y; 1998; ():32. PubMed ID: 11367504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3TC approved for children.
    Highleyman L
    BETA; 1999 Apr; 12(2):5. PubMed ID: 11366698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamivudine (3TC) approved for combination use with AZT.
    James JS
    AIDS Treat News; 1995 Dec; (no 236):1-5. PubMed ID: 11363049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epivir for younger children.
    Vazquez E
    Posit Aware; 1999; 10(3):26. PubMed ID: 11366765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved but not new.
    Vazquez E
    Posit Aware; 1997; 8(6):19. PubMed ID: 11364855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two drugs in one pill.
    Vazquez E
    Posit Aware; 1997; 8(6):19. PubMed ID: 11364854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generic nucleoside approved.
    AIDS Patient Care STDS; 2005 Aug; 19(8):540. PubMed ID: 16163787
    [No Abstract]   [Full Text] [Related]  

  • 10. Two drugs better than one for children.
    AIDS Alert; 1997 Oct; 12(10):120. PubMed ID: 11364720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA notifications. Tentative approval of generic lamivudine.
    AIDS Alert; 2005 Jul; 20(7):82. PubMed ID: 16114112
    [No Abstract]   [Full Text] [Related]  

  • 12. Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy.
    Matthews GV; Bartholomeusz A; Locarnini S; Ayres A; Sasaduesz J; Seaberg E; Cooper DA; Lewin S; Dore GJ; Thio CL
    AIDS; 2006 Apr; 20(6):863-70. PubMed ID: 16549970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunistic infections update.
    Proj Inf Perspect; 1998 Dec; (26):5-6. PubMed ID: 11366497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA notifications. FDA grants approval of generic lamivudine tablets.
    AIDS Alert; 2009 Dec; 24(12):142-3. PubMed ID: 20063478
    [No Abstract]   [Full Text] [Related]  

  • 15. Ninety-six-week efficacy of combination therapy with lamivudine and tenofovir in patients coinfected with HIV-1 and wild-type hepatitis B virus.
    Bani-Sadr F; Palmer P; Scieux C; Molina JM
    Clin Infect Dis; 2004 Oct; 39(7):1062-4. PubMed ID: 15472862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination trials with 3TC/AZT stopped as clinical benefit shown.
    AIDS Patient Care STDS; 1996 Dec; 10(6):378. PubMed ID: 11361565
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA notifications. FDA approval for generic lamivudine/zidovudine.
    AIDS Alert; 2008 Jan; 23(1):12. PubMed ID: 18572476
    [No Abstract]   [Full Text] [Related]  

  • 18. Combo therapy for children and adolescents.
    Treat Rev; 1997 Aug; (No 25):7. PubMed ID: 11364620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abacavir gets green light from FDA advisory board. Food and Drug Administration.
    TreatmentUpdate; 1998 Nov; 10(9):3-4. PubMed ID: 11365924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS treatment. A step toward cheaper anti-HIV therapy.
    Cohen J
    Science; 2005 Feb; 307(5710):653. PubMed ID: 15692020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.